As TRIO-US manages clinical trials at more than 15 community-based oncology practices representing 155 physicians at locations across the United States there is a strong chance there is a clinical trial you can participate in. TRIO-US is dedicated to the search for innovative and quality treatment options for its cancer patients. The network provides patients access to clinical trials with promising new treatments that are usually only available to patients in larger cities, with access to academic centers, and offers the same high-quality UCLA standards as in campus-based studies. TRIO-US has conducted trials that have led to the approvals of various targeted therapies such as Herceptin, Avastin, Tarceva, Gleevec and Sutent, for breast, lung, kidney and colorectal cancers, as well as chronic myelogenous leukemia and gastrointestinal stromal tumors.
Please visit our Clinical Trials Search Tool to review trials currently being conducted at our Network locations.